Johnson & Johnson

Last updated September 27, 2026

Organization details

Legal name
Johnson & Johnson
Former names
Johnson & Johnson et AL
Ownership
Public
Status
Active
SIC code
2834 — Pharmaceutical Preparations
Jurisdiction of incorporation
New Jersey
Headquarters city
New Brunswick
Headquarters state / province
New Jersey
Headquarters country
United States
Fiscal year end
January
Ticker symbol
JNJ
Primary stock exchange
NYSE

Identifiers

SEC CIK
0000200406
EIN
22-1024240

Board of directors

Chief executives

Joaquin Duato · CEO and Chairman of the Board
Dates unknown

Director election results

Annual meeting of April 23, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.

Board connections

15 of this board's directors also sit on 26 other boards.

Network of Johnson & Johnson's board connections Honeywell International Inc. Honeywell Internationa... JP Morgan Chase & Co. JP Morgan Chase & Co. Tempus AI Inc. Tempus AI Inc. Alignment Healthcare Inc. Alignment Healthcare I... Apple Inc. Apple Inc. Best Buy Co. Inc. Best Buy Co. Inc. Chevron Corporation Chevron Corporation Exelixis Inc. Exelixis Inc. Fortune Brands Innovations Inc. Fortune Brands Innovat... General Mills Inc. General Mills Inc. Graham Holdings Company Graham Holdings Compan... Honeywell Aerospace Inc. Honeywell Aerospace In... Huntsman Corporation Huntsman Corporation Intercontinental Exchange Inc. Intercontinental Excha... International Business Machines Corporation International Business... LPL Financial Holdings Inc. LPL Financial Holdings... Alex Gorsky Alex Gorsky Anne M. Mulcahy Anne M. Mulcahy D. Scott Davis D. Scott Davis Daniel E. Pinto Daniel E. Pinto Darius Adamczyk Darius Adamczyk Eugene A. Woods Eugene A. Woods Jennifer A. Doudna Jennifer A. Doudna John G. Morikis John G. Morikis Marillyn A. Hewson Marillyn A. Hewson Mark A. Weinberger Mark A. Weinberger Johnson & Johnson
Shared director Other board Same sector +10 more in the list below

Insider trades

All notable trades →

From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.

Bought, last 12 months
$257,688
1 purchase by 1 insider
Sold, last 12 months
$154,853,126
29 sales by 10 insiders
Date Insider Transaction Shares Price Value
Sep 2, 2026 Schmid Timothy Officer (EVP, WW Chair, MedTech) Option exercise +11,070 $131.94 $1,460,576
Sep 2, 2026 Schmid Timothy Officer (EVP, WW Chair, MedTech) Open-market sale −11,070 $274.74 $3,041,372
Sep 2, 2026 Schmid Timothy Officer (EVP, WW Chair, MedTech) Option exercise +22,527 $151.41 $3,410,813
Sep 2, 2026 Schmid Timothy Officer (EVP, WW Chair, MedTech) Open-market sale −22,527 $274.74 $6,189,068
Aug 17, 2026 Jennifer L. Taubert Officer (EVP, WWC. Innovative Medicine) Option exercise +15,000 $115.67 $1,735,050
Aug 17, 2026 Jennifer L. Taubert Officer (EVP, WWC. Innovative Medicine) Open-market sale −15,000 $263.36 $3,950,400
Aug 13, 2026 Joaquin Duato Director, Officer (CEO and Chairman of the Board) Option exercise +123,291 $115.67 $14,261,070
Aug 13, 2026 Joaquin Duato Director, Officer (CEO and Chairman of the Board) Open-market sale −20,976 $262.00 $5,495,712
Aug 13, 2026 Joaquin Duato Director, Officer (CEO and Chairman of the Board) Open-market sale −102,315 $261.00 $26,704,215
Aug 6, 2026 Forminard Elizabeth Officer (EVP, Chief Legal Officer) Option exercise +9,344 $131.94 $1,232,847
Aug 6, 2026 Forminard Elizabeth Officer (EVP, Chief Legal Officer) Open-market sale −9,344 $257.76 $2,408,463
Aug 6, 2026 Forminard Elizabeth Officer (EVP, Chief Legal Officer) Open-market sale −6,574 $255.93 $1,682,497
Aug 5, 2026 Joaquin Duato Director, Officer (CEO and Chairman of the Board) Open-market sale −41,957 $258.06 $10,827,256
Aug 5, 2026 Joaquin Duato Director, Officer (CEO and Chairman of the Board) Open-market sale −6,523 $258.74 $1,687,755
Jul 20, 2026 Vanessa Broadhurst Officer (EVP, Global Corp Affairs) Option exercise +11,129 $129.51 $1,441,317

Reviews (0)

Sign in to write a review.

No reviews yet. Be the first to write one.

We use cookies to run this site and, with your permission, to measure traffic and support the affiliate links that help fund it.